BREAKING
NGX All-Share Index gains 412 points — MTN, Zenith, GTCo top movers CBN holds MPR at 27.5% — rate cuts possible Q3 2026 Dangote Refinery begins export of refined petroleum products SEC Nigeria approves new digital assets trading framework NGX All-Share Index gains 412 points — MTN, Zenith, GTCo top movers CBN holds MPR at 27.5% — rate cuts possible Q3 2026
LIVE
NGX 104,562 ▲0.42% | USD/NGN ₦1,614 ▼0.12% | BTC $84,210 ▲1.24% | DANGCEM ₦412 ▲1.10% | GTCO ₦58.45 ▲0.77% | MTNN ₦224.80 ▼0.31% | ZENITH ₦42.15 ▲0.60% | NGX 104,562 ▲0.42% | USD/NGN ₦1,614 ▼0.12% | BTC $84,210 ▲1.24%
₦90K
Weekly Giveaway — 5 Winners Every Week
1st: ₦50K  |  2nd–5th: ₦10K each  |  Be active to win
1,103Members
19,706Threads
26,424Posts
JOIN NOW

#obesitytreatment

  • Weekly Giveaway for our active users. N50,000 per Week. Do you want to contribute to this community? We are looking for contribution? What is hot right now? Sign up and get in on the ground floor of the newest, fastest growing Nigerian forum!
  1. A

    Eli Lilly Expands Access to Zepbound with Affordable Single-Dose Vials for Obesity Treatment

    Eli Lilly and Company (NYSE: LLY) has launched Zepbound® (tirzepatide) single-dose vials, available through its LillyDirect® self-pay channel, significantly expanding access to obesity treatment. These vials are priced at least 50% lower than other incretin (GLP-1) medicines for obesity...